Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;43(3):639-648.
doi: 10.1111/liv.15471. Epub 2022 Nov 15.

Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up study

Kim N van Munster  1 , Bregje Mol  1 , Jorn C Goet  2 , Sanne N van Munster  1 , Rinse K Weersma  3 , Annemarie C de Vries  2 , Adriaan J van der Meer  2 , Akin Inderson  4 , Joost P Drenth  5 , Karel J van Erpecum  6 , Kirsten Boonstra  7 , Ulrich Beuers  1 , Marcel G W Dijkgraaf  8 , Cyriel Y Ponsioen  1 ; EpiPSC2 Study Group
Affiliations

Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up study

Kim N van Munster et al. Liver Int. 2023 Mar.

Abstract

Background & aims: Primary sclerosing cholangitis (PSC) is a progressive, cholestatic liver disease which greatly impacts the lives of individuals. Burden of disease due to shortened life expectancy and impaired quality of life is ill-described. The aim of this study was to assess long-term disease burden in a large population-based registry with regard to survival, clinical course, quality adjusted life years (QALYs), medical consumption and work productivity loss.

Methods: All PSC patients living in a geographically defined area covering ~50% of the Netherlands were included, together with patients from the three liver transplant centres. Survival was estimated by competing risk analysis. Proportional shortfall of QALYs during disease course was measured relative to a matched reference cohort using validated questionnaires. Work productivity loss and medical consumption were evaluated over time.

Results: A total of 1208 patients were included with a median follow-up of 11.2 year. Median liver transplant-free survival was 21.0 years. Proportional shortfall of QALYs increased to 48% >25 years after diagnosis. Patients had on average 12.4 hospital contact days among which 3.17 admission days per year, annual medical costs were €12 169 and mean work productivity loss was 25%.

Conclusions: Our data quantify for the first time disease burden in terms of QALYs lost, clinical events, medical consumption, costs as well as work productivity loss, and show that all these are substantial and increase over time.

Keywords: PSC; QALY; disease burden; medical costs; survival; work productivity loss.

PubMed Disclaimer

References

REFERENCES

    1. Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet (London, England). 2018;391(10139):2547-2559.
    1. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38(4):610-615.
    1. Steenstraten IC, Sebib Korkmaz K, Trivedi PJ, et al. Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation. Aliment Pharmacol Ther. 2019;49(6):636-643.
    1. Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58(6):2045-2055.
    1. Weismuller TJ, Trivedi PJ, Bergquist A, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary Sclerosing cholangitis. Gastroenterology. 2017;152(8):1975-84.e8.

Publication types

LinkOut - more resources